EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Three-dimensional tissue engineered skeletal muscle modelling facioscapulohumeral muscular dystrophy

Marnix Franken, Erik van der Wal, Dongxu Zheng, Bianca den Hamer, Patrick J van der Vliet, Richard J L F Lemmers iD, Anita van den Heuvel iD, Alexandra L Dorn, Cas G A Duivenvoorden, Stijn L M In 't Groen, Christian Freund, Bert Eussen und 5 weitere

Brain · 2025

DOI: 10.1093/brain/awae379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Marnix Franken und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Muscle, Skeletal, Tissue Engineering. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health-Holland, Top Sector Life Sciences & Health, AFM Téléthon, European Reference Network for Rare Neuromuscular Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Facioscapulohumeral muscular dystrophy (FSHD) is caused by sporadic misexpression of the transcription factor double homeobox 4 (DUX4) in skeletal muscles. So far, monolayer cultures and animal models have been used to study the disease mechanism of FSHD and for development of FSHD therapy, but these models do not fully recapitulate the disease and there is a lack of knowledge on how DUX4 misexpression leads to skeletal muscle dysfunction. To overcome these barriers, we have developed a 3D tissue engineered skeletal muscle (3D-TESM) model by generating genetically matched myogenic progenitors from human induced pluripotent stem cells of three mosaic FSHD patients. 3D-TESMs derived from genetically affected myogenic progenitors recapitulated pathological features including DUX4 and DUX4 target gene expression, smaller myofibre diameters and reduced absolute forces upon electrical stimulation. RNA-sequencing data illustrated increased expression of DUX4 target genes in 3D-TESMs compared with 2D myotubes, and cellular differentiation was improved by 3D culture conditions. Treatment of 3D-TESMs with three different small molecules identified in drug development screens in 2D muscle cultures showed no improvements, and sometimes even declines, in contractile force and sarcomere organization. These results suggest that these compounds either have a detrimental effect on the formation of 3D-TESMs, an effect that might have been overlooked or was challenging to detect in 2D cultures and in vivo models, and/or that further development of the 3D-TESM model is needed. In conclusion, we have developed a 3D skeletal muscle model for FSHD that can be used for preclinical research focusing on DUX4 expression and downstream pathways of FSHD in relationship to contractile properties. In the future, we expect that this model can also be used for preclinical drug screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, FacioscapulohumeralMuscle, SkeletalTissue EngineeringHumansHomeodomain ProteinsInduced Pluripotent Stem CellsCell DifferentiationMuscle Fibers, SkeletalCells, CulturedMale

Stichwörter der Autor:innen

disease modellingdouble homeobox 4facioscapulohumeral muscular dystrophyhuman induced pluripotent stem cellsmosaicthree-dimensional tissue engineering

Substanzen

Homeodomain ProteinsDUX4L1 protein, human

Autor:innen und Institutionen

  • Department of Human Genetics, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands.
  • Department of Clinical Genetics, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
  • Department of Pediatrics, Erasmus University Medical Center, 3015 GE Rotterdam, The Netherlands.
  • Center for Lysosomal and Metabolic Diseases, Erasmus University Medical Center, 3015 GE Rotterdam, The Netherlands.
  • Leiden hiPSC Centre, Department of Anatomy and Embryology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands.
  • Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA.

ORCID-Profile: Richard J L F Lemmers, Anita van den Heuvel, Jessica C de Greef

Förderung

  • Health-Holland, Top Sector Life Sciences & Health
  • AFM Téléthon
  • European Reference Network for Rare Neuromuscular Diseases

Zitieren

APA

Franken, M., van der Wal, E., Zheng, D., den Hamer, B., van der Vliet, P. J., Lemmers, R. J. L. F., van den Heuvel, A., Dorn, A. L., Duivenvoorden, C. G. A., In 't Groen, S. L. M., Freund, C., Eussen, B., Tawil, R., van Engelen, B. G. M., Pijnappel, W. W. M. P., van der Maarel, S. M., & de Greef, J. C. (2025). Three-dimensional tissue engineered skeletal muscle modelling facioscapulohumeral muscular dystrophy. Brain. https://doi.org/10.1093/brain/awae379

Vancouver

Franken M, van der Wal E, Zheng D, den Hamer B, van der Vliet PJ, Lemmers RJLF, et al. Three-dimensional tissue engineered skeletal muscle modelling facioscapulohumeral muscular dystrophy. Brain. 2025. doi:10.1093/brain/awae379

BibTeX
@article{Franken2025,
  author = {Franken, Marnix and van der Wal, Erik and Zheng, Dongxu and den Hamer, Bianca and van der Vliet, Patrick J and Lemmers, Richard J L F and van den Heuvel, Anita and Dorn, Alexandra L and Duivenvoorden, Cas G A and In 't Groen, Stijn L M and Freund, Christian and Eussen, Bert and Tawil, Rabi and van Engelen, Baziel G M and Pijnappel, W W M Pim and van der Maarel, Silvère M and de Greef, Jessica C},
  title = {Three-dimensional tissue engineered skeletal muscle modelling facioscapulohumeral muscular dystrophy},
  journal = {Brain},
  year = {2025},
  doi = {10.1093/brain/awae379}
}
Kostenlos starten →